The Ferys Thesis
Our approach is rooted in deep operational experience rather than the passive "spray and pray" model. We reject the index-fund mentality of venture capital.
Instead, we concentrate high-conviction capital and hands-on expertise to de-risk execution. We are active partners, not just allocators—investing our operational DNA alongside our capital to ensure commercial success.
Leadership Team
Decades of execution experience in healthcare and venture capital.
David Cubbin
Partner
Ex-Challenger EMEA Head, Ex-Aescuvest Partner, Ex-Cure Capital CEO. Deep expertise in management, culture and fundraising.
Sebastian Gührs
Partner
Ex-Aescuvest CIO, Ex-Bavarian Capital Investor. Deep expertise in technology and healthcare regulations.
Selected Portfolio
High-conviction investments in transformative healthcare solutions.
Neteera
MedTech / Monitoring
The Thesis
Staffing crisis and reactive spot-checks leave patients vulnerable.
The Solution
Contactless, continuous, FDA-cleared monitoring. Passive sensing technology that requires no wearables.
Virasoft
Digital Pathology / AI
The Thesis
Digital Pathology & AI. Transforming diagnostics with precision and speed.
The Solution
AI-powered diagnostic platform enabling faster, more accurate pathology workflows and remote consultations.
Cerryx
AgTech / Biotech
The Thesis
Precision Biotics. An all-in-one feed additive that reduces emissions and replaces antibiotics in livestock.
The Solution
Sustainable feed additives that improve animal health while significantly lowering methane emissions.
Partner with Ferys
Whether you are a founder building the future of healthcare or an LP seeking institutional-grade exposure, we want to hear from you.